BeyeNETWORK - The Global Vision for BI and Beyond

UK’s NIHR Biomedical Research Centre for Mental Health Selects InforSense

Published: December 2, 2008

The partnership was created to advance the development of Alzheimer’s early diagnostic tools and develop personalized medicine treatments within mental health research.

Leading next generation business intelligence software provider, InforSense, recently announced that the UK’s National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust (SLaM) and King’s College London’s Institute of Psychiatry will use the InforSense Translational Research Solution for Alzheimer’s disease studies.

The partnership was created to advance the development of Alzheimer’s early diagnostic tools and develop personalized medicine treatments within mental health research.

This marks the first time that informaticians, researchers and clinicians will be able to directly access their entire patient and ‘omics’ data  through a common data analysis platform. The InforSense solution will eliminate errors associated with manual data processes and bottlenecks relating to data access and analysis by non specialist end users. Specifically the InforSense Translational Research Solution will help to integrate and analyze patient, genotyping, transcriptomics, proteomics and MRI data to support the identification of biomarkers.